Unexpected Low-Temperature Behaviour of Piroxicam MonohydrateFUCKE, Katharina; EDWARDS, Alison J; PROBERT, Michael R et al.ChemPhysChem (Print). 2013, Vol 14, Num 4, pp 675-679, issn 1439-4235, 5 p.Article

Differential permeation of piroxicam-loaded PLGA micro/nanoparticles and their in vitro enhancementSHANKARAYAN, Raju; KUMAR, Sumit; MISHRA, Prashant et al.Journal of nanoparticle research. 2013, Vol 15, Num 3, issn 1388-0764, 1496.1-1496.13Article

A pharmacokinetic study of piroxicam in childrenDIX, P; PROSSER, D. P; STREETE, P et al.Anaesthesia. 2004, Vol 59, Num 10, pp 984-987, issn 0003-2409, 4 p.Article

Inclusion complexes of piroxicam with β-cyclodextrin derivatives in comparison with the natural β-cyclodextrin: 1st communication: Preparation and physicochemical characterizationELKHESHEN, Seham A; AHMED, Sayed M; SAMMOUR, Omima A et al.Pharmazeutische Industrie. 2002, Vol 64, Num 6, pp 612-620, issn 0031-711XArticle

Characterization of piroxicam crystal modificationsVRECER, F; VRBINC, M; MEDEN, A et al.International journal of pharmaceutics. 2003, Vol 256, Num 1-2, pp 3-15, issn 0378-5173, 13 p.Conference Paper

A case of generalized fixed drug eruption due to a piroxicam plasterRHO, Y. K; YOO, K. H; KIM, B. J et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 2, pp 204-205, issn 0307-6938, 2 p.Article

Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel: A Preliminary Open-Label Study Utilizing a New Clinical ScoreCAMPIONE, Elena; DILUVIO, Laura; PATERNO, Evelin Jasmine et al.American journal of clinical dermatology. 2010, Vol 11, Num 1, pp 45-50, issn 1175-0561, 6 p.Article

Spectrofluorometric determination of piroxicamDAMIANI, P. C; BEARZOTTI, M; CABEZON, M et al.Journal of pharmaceutical and biomedical analysis. 1998, Vol 17, Num 2, pp 233-236, issn 0731-7085Article

Éruption bulleuse génitale récidivante = Recurrent bullous genital eruptionDESCAMPS, V.Images en dermatologie. 2012, Vol 5, Num 4-5, pp 98-99, issn 1964-4167, 2 p.Article

Template occluded SBA-15: An effective dissolution enhancer for poorly water-soluble drugFU TINGMING; GUO LIWEI; LE KANG et al.Applied surface science. 2010, Vol 256, Num 23, pp 6963-6968, issn 0169-4332, 6 p.Article

Nanostructured Microspheres Produced by Supercritical Fluid Extraction of EmulsionsDELLA PORTA, Giovanna; REVERCHON, Ernesto.Biotechnology and bioengineering. 2008, Vol 100, Num 5, pp 1020-1033, issn 0006-3592, 14 p.Article

Synthesis of deuterium-labelled meloxicam and piroxicamBALSSA, Frederic; BONNAIRE, Yves.Journal of labelled compounds & radiopharmaceuticals. 2007, Vol 50, Num 3-4, pp 207-210, issn 0362-4803, 4 p.Article

Spectrofluorimetric determination of 2-aminopyridine as a potential impurity in piroxicam and tenoxicam within the pharmacopoeial limitBARARY, Magda H; ABDEL-HAY, Mohamed H; SABRY, Suzy M et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 1, pp 221-226, issn 0731-7085, 6 p.Article

Thermal stability of piroxicam: Part 2. Kinetic study of the active substance under isothermal conditions : Current Topics of AICAT 2012TITA, Bogdan; MARIAN, Eleonora; FULIAS, Adriana et al.Journal of thermal analysis and calorimetry. 2013, Vol 112, Num 1, pp 367-374, issn 1388-6150, 8 p.Conference Paper

Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicateAMBROGI, V; PERIOLI, L; MARMOTTINI, F et al.European journal of pharmaceutical sciences. 2007, Vol 32, Num 3, pp 216-222, issn 0928-0987, 7 p.Article

Enhanced bioavailability of piroxicam via salt formation with ethanolaminesGWAK, Hye-Sun; CHOI, Jun-Shik; CHOI, Hoo-Kyun et al.International journal of pharmaceutics. 2005, Vol 297, Num 1-2, pp 156-161, issn 0378-5173, 6 p.Article

Development and validation of chemometrics-assisted spectrophotometry and micellar electrokinetic chromatography for the determination of four-component pharmaceuticalsNEPOTE, Alberto J; VERA-CANDIOTTI, Luciana; WILLINER, Maria R et al.Analytica chimica acta. 2003, Vol 489, Num 1, pp 77-84, issn 0003-2670, 8 p.Article

Fast dissolving films made of maltodextrinsCILURZO, Francesco; CUPONE, Irma E; MINGHETTI, Paola et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 70, Num 3, pp 895-900, issn 0939-6411, 6 p.Article

Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicamCILURZO, Francesco; SELMIN, Francesca; MINGHETTI, Paola et al.European journal of pharmaceutical sciences. 2005, Vol 24, Num 4, pp 355-361, issn 0928-0987, 7 p.Article

Topical absorption of piroxicam from organogels : in vitro and in vivo correlationsPENZES, T; BLAZSO, G; AIGNER, Z et al.International journal of pharmaceutics. 2005, Vol 298, Num 1, pp 47-54, issn 0378-5173, 8 p.Article

Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal deliveryALSARRA, Ibrahim A.Journal of microencapsulation. 2009, Vol 26, Num 3, pp 272-278, issn 0265-2048, 7 p.Article

Spectrofluorimetric determination of piroxicam in pharmaceutical preparations and spiked human serum using micellar mediaMANZOORI, Jamshid L; AMJADI, Mohammad.Mikrochimica acta (1966. Print). 2003, Vol 143, Num 1, pp 39-44, issn 0026-3672, 6 p.Article

Polymorphism in piroxicamSHETH, Agam R; BATES, Simon; MULLER, Francis X et al.Crystal growth & design. 2004, Vol 4, Num 6, pp 1091-1098, issn 1528-7483, 8 p.Article

Improved dissolution behaviour of steam-granulated piroxicamCAVALLARI, Cristina; ABERTINI, Beatrice; GONZALEZ-RODRIGUEZ, Marisa L et al.European journal of pharmaceutics and biopharmaceutics. 2002, Vol 54, Num 1, pp 65-73, issn 0939-6411Article

Hydrogen bonding effects in the photophysics of a drug, Piroxicam, in homogeneous media and dioxane-water mixturesANDRADE, S. M; COSTA, S. M. B.PCCP. Physical chemistry chemical physics (Print). 1999, Vol 1, Num 18, pp 4213-4218, issn 1463-9076Article